Select company
- Ticker/CompanyMarket Cap.
No results found
Select metric
Pick a metric...
55.25%EBIT Margin
VS
Market
Sector
Industry
History
$ 14.26Close
$ 8.21 - $ 14.6 52-Week Range
Ticker Information
Ticker
TBPHCompany Name
THERAVANCE BIOPHARMA INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQTHERAVANCE BIOPHARMA INC - EBIT Margin Chart Analysis (TTM)
From
Zoom
1Y
3Y
5Y
10Y
TBPH - EBIT % Historical data
| Date | Earning Before Interest & Taxes (EBIT) | EBIT Margin | Revenues |
|---|---|---|---|
| 6/30/2025 | $ 42.66M | 55.25% | $ 77.2M |
| 3/31/2025 | $ -45.79M | -70.16% | $ 65.27M |
| 12/31/2024 | $ -42.07M | -65.34% | $ 64.38M |
| 9/30/2024 | $ -38.16M | -60.4% | $ 63.19M |
| 6/30/2024 | $ -35.72M | -57.59% | $ 62.02M |
| 3/31/2024 | $ -34.76M | -56.51% | $ 61.51M |
| 12/31/2023 | $ -46.92M | -81.71% | $ 57.42M |
| 9/30/2023 | $ -56.23M | -103.17% | $ 54.51M |
| 6/30/2023 | $ 1.05B | 2050.63% | $ 51.27M |
| 3/31/2023 | $ 1.07B | 2200.23% | $ 48.57M |
Key Performance Insights, Last 5 Years
- THERAVANCE BIOPHARMA INC's latest trailing twelve months (TTM) EBIT % stands at -294.41%.
- Over the past 5 years, THERAVANCE BIOPHARMA INC's average EBIT % has been 286.2%.
- The median EBIT % for THERAVANCE BIOPHARMA INC during this period was -75.93%
- THERAVANCE BIOPHARMA INC reached its highest EBIT % over the past 5 years at 2200.23%.
- The lowest EBIT % recorded by THERAVANCE BIOPHARMA INC in the same timeframe -355.72%
THERAVANCE BIOPHARMA INC's EBIT % vs. competitors
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
EBIT % Benchmarks
Similar metrics to Revenues:
- EBITDA Margin - [Calculation] A company’s [EBITDA] as a percentage of [Revenue]. Measures how much earnings a company produces for each dollar of revenue generated before interest, taxes, depreciation and amortization.
- Net Margin - [Calculation] A company’s Net Income [NetIncCmn] as a percentage of [Revenue]. Measures how much earnings a company produces for each dollar of revenue generated.
- Free Cash Flow Margin - [Calculation] A company’s Free Cash Flow [FCF] as a percentage of [Revenue]. Measures how much cash a company produces for each dollar of revenue generated.
- Revenues - [Income Statement] The sum of revenue generated from all sold goods and rendered services.
- Operating Margin - [Calculation] A company’s operating income [OpInc] as a percentage of [Revenue]. The operating margin measures how much profit a company produces for each dollar of revenue generated, after paying for variable costs such as wages and raw materials.
Definition of EBIT Margin
[Calculation] A company’s [EBIT] as a percentage of [Revenue]. Measures how much earnings a company produces for each dollar of revenue generated before interest and taxes.EBIT / Revenues
(=) EBIT % EBIT % for THERAVANCE BIOPHARMA INC is calculated as follows: EBIT [ $ -243.26M ] / Revenues [ $ 82.63M ]
(=) EBIT % [ -294.41% ] TBPH - EBIT Margin, Last 5 years
-355.72%
Minimum
Mar 31, 2021
2200.23%
Maximum
Mar 31, 2023
286.2%
Average
-75.93%
Median
EBIT % Benchmark AnalysisMarket
The chart above depicts the distribution of EBIT % for companies in the Total Stock Market. The average EBIT % of the companies is 9.54% with a standard deviation of 23.96%.
The following table provides additional summary stats:
EBIT % in the Market:
| filtered constituents | 3.26K |
|---|---|
| min | -73.16% |
| max | 83.08% |
| average | 9.54% |
| median | 9.01% |
| std | 23.96% |